Primary Record
mianserin
- In stock
- 8,831 g
- Purity
- 98.2 %
- CAS
- 24219-97-4
Compound Identifiers & Properties
- CAS
- 24219-97-4
- PubChem CID
- 4184
- SMILES
- CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42
- Canonical SMILES
- CN1CCN2c3ccccc3Cc3ccccc3C2C1
Names & Synonyms
- mianserin
- Mianserine
- Mianserina
- Mianserinum
- Tolvon
- Mianseryna
- Norval
- Mianseryna [Polish]
- Tolvan
- Mianserin HCl
- Bolvidon
- Lerivon
- mianserin a
- 24219-97-4
- Mianserine [INN-French]
- Mianserinum [INN-Latin]
- Mianserin hydrochloride
- mianserine HCl
- Mianserin?
- Mianserina [INN-Spanish]
- Mianserin (INN)
- Mianserin [INN:BAN]
- Mianserin-d3
- S(+)-Mianserin
- Tolvon (TN)
- (+/-)-Mianserin
- Bolvidon (TN)
- Norval (TN)
- Tolvin (TN)
- (+-)-Athymil
- Mianserine hydrochloride
- Mianserin Monohydrochloride
- Spectrum_001810
- PS32 - Mianserin
- MIANSERIN [INN]
- (S)-(+)-Mianserin
- MIANSERIN [MI]
- AC1L1HLP
- MIANSERIN [HSDB]
- Prestwick0_000099
- Prestwick1_000099
- Prestwick2_000099
- Prestwick3_000099
- RefChem:158482
- Spectrum2_001203
- Spectrum3_001836
- Spectrum4_001260
- Spectrum5_001772
- 250PJI13LM
- CHEMBL6437
- MIANSERIN [VANDF]
- UNII-250PJI13LM
- DTXSID6023317
- ORG GB 94
- Biomol-NT_000135
- CHEBI:51137
- D0R6RO
- HSDB 7182
- MIANSERIN [WHO-DD]
- DTXCID003317
- UEQUQVLFIPOEMF-UHFFFAOYSA-N
- Lopac0_000744
- Oprea1_703627
- SCHEMBL18020
- BSPBio_000058
- BSPBio_003511
- GTPL135
- KBioGR_001820
- KBioSS_002303
- cid_68551
- MLS000069681
- DivK1c_000844
- EINECS 246-088-6
- SPBio_000986
- SPBio_001997
- BPBio1_000064
- BPBio1_000331
- orb1705061
- C18H20N2
- J16.389I
- SCHEMBL29356897
- BDBM31005
- KBio1_000844
- KBio2_002301
- KBio2_004869
- KBio2_007437
- KBio3_003016
- BRN 0755346
- CID4184
- N06AX03
- NINDS_000844
- HMS2089A04
- BCA15288
- HY-B0188
- Tox21_110191
- AC-631
- BDBM50222218
- EBC-26370
- NCGC00015656-06
- PDSP1_001532
- PDSP2_001516
- 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
- AKOS005216268
- Tox21_110191_1
- C18-H20-N2
- CCG-204829
- CS-2078
- DB06148
- SDCCGSBI-0050722.P004
- 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
- IDI1_000844
- NCGC00015656-04
- NCGC00015656-05
- NCGC00015656-08
- NCGC00015656-09
- NCGC00015656-10
- NCGC00015656-12
- NCGC00015656-23
- NCGC00024926-03
- NCGC00024926-04
- AN-15691
- DA-65446
- LS-61197
- SMR000058472
- TS-08152
- SBI-0050722.P003
- CAS-24219-97-4
- A1796
- AM20041174
- FT-0697022
- NS00010650
- X5019
- D08216
- EN300-18559884
- L000736
- Q416701
- Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
- 1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine
- BRD-A19661776-001-01-5
- BRD-A19661776-003-05-2
- BRD-A19661776-003-16-9
- BRD-A19661776-003-25-0
- BRD-A19661776-003-26-8
- BRD-A19661776-003-27-6
- BRD-A19661776-003-28-4
- 51152-88-6
- Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-
- 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene
- 5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene
- 1,2,3,4,10,14B-HEXAHYDRO-2-METHYLDIBENZO(C,F)-PYRAZINO(1,2-A)AZEPINE
- 2-methyl-1,2,3,4,10,14b-hexahydro-2H-pyrazino[1,2-f]morphanthridine
- 2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine #
- 5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene
- 78684-63-6
- Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)-
- Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bS)-
- (7S)-5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene
- 21535-47-7
- 246-088-6
- 5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(15),8(13),9,11,16,18-hexaene
- 5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8,10,12,15,17-hexaene
- 81957-76-8
- Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine; (+/-)-Mianserin; Mianserin; Mianserine